![]() | |
Clinical data | |
---|---|
Trade names | Hetacin, Versapen |
AHFS/Drugs.com | Veterinary Use |
Routes of administration | Intramammary injection |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.020.466 |
Chemical and physical data | |
Formula | C19H23N3O4S |
Molar mass | 389.47 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Hetacillin is a beta-lactam antibiotic that is part of the aminopenicillin family. It is a prodrug and has no antibacterial activity itself, [1] but quickly splits off acetone in the human body to form ampicillin, [2] which is active against a variety of bacteria.
Hetacillin can be administered orally. The potassium salt, hetacillin potassium, is administered by injection, either intravenously [3] or intramuscularly. [4] It is sold under the trade name Hetacin for intramammary injection in veterinary use. [5]
Hetacillin was withdrawn from the market for human use when the discovery was made that it had no advantages over ampicillin. [6]
Hetacillin is prepared from ampicillin and acetone. In aqueous solutions it is unstable, with a half life of 15 to 30 minutes at 37 °C (99 °F) and pH 7, quickly releasing acetone again. [7]